NIH-funded research R01 grant

Blood pressure gene risk score used to guide treatment in adults with hypertension

Official title: Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical Trial

Funded at University of Alabama at Birmingham · NIH-11378697 · Data updated 2026-11-12

A study tests whether sharing a person’s blood pressure genetic risk score helps clinicians tailor treatment and improve blood pressure control in adults with high blood pressure.

More Blood Pressure research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startAugust 1, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$726,809
NIH project number5R01HL176882-02
Project IDNIH-11378697 on NIH RePORTER

Who could benefit from this research

Could help

Adults with hypertension or elevated blood pressure who are willing to use genetic risk information to guide their care.

Less likely to help

People who do not respond to standard therapies or who are not interested in using genetic risk information may receive no additional benefit.

What this research studies

This project uses a polygenic risk score for systolic blood pressure to guide treatment decisions in a two-arm randomized trial. Participants are adults with elevated blood pressure who will be followed over time to see if knowing their genetic risk improves adherence to medications and lifestyle changes. The trial combines genetic information with standard care to see if outcomes like blood pressure control and cardiovascular risk can improve. Researchers will monitor adherence, blood pressure measurements, and clinical events to determine if the approach provides added benefit beyond traditional risk factors.

Why it matters

Potential benefit: If successful, patients may achieve better blood pressure control and lower cardiovascular risk through personalized treatment plans.

How similar studies have gone: Prior work suggests genetic risk information can influence risk perception and treatment adherence, but results in hypertensive adults are still emerging.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Arora, Pankaj — University of Alabama at Birmingham
  • Study coordinator: Arora, Pankaj

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.